GENE ONLINE|News &
Opinion
Blog

Daniel Ojeda

WRITTEN BY Daniel Ojeda

Genomic Profiling Reveals Multiple Resistance Mechanisms of Cancers Against KRAS Inhibitors
2021-06-25
Novartis’ Expensive Gene Therapy for SMA Reasserts its Efficacy in Two Clinical Trials
2021-06-24
From Great Challenges to Great Opportunities: An Outlook on US-China Biotech Relationships
2021-06-18
Is the Path to Public Market Smooth? A Candid Discussion on SPACs
2021-06-15
Datavant, Ciox Health’s $7B Merger to Create the Largest Health Data Exchange Company
2021-06-10
Day 4 ASCO 2021 Roundup: Immunotherapy Candidates Show Promise in Early Studies
2021-06-09
MorphoSys Partners with Royalty Pharma to Fund $1.7B Constellation Pharmaceuticals Buyout
2021-06-05
Amgen, Kyowa Kirin Renew Long-Standing Partnership to Promote Atopic Dermatitis Therapy
2021-06-02
We Have a Winner! Amgen Grabs First FDA Nod in the Race for Undruggable KRAS
2021-05-30
Larimar Drops $95M Private Financing Plans after FDA Orders Clinical Hold on Rare Disease Therapy
2021-05-27
Xeris to Snag Bucks County-based Strongbridge Biopharma for $267 Million
2021-05-25
Exscientia Signs $1 Billion Worth AI Deal to Boost BMS’ Drug Discovery Pipeline
2021-05-21
Emerging Gene Editing Technologies and Applications
2021-05-19
ASGCT21 Highlights: Present Trends and Future Directions of Gene and Cell Therapies in Immuno-Oncology
2021-05-14
Ginkgo Bioworks to Go Public Via a Colossal SPAC Deal Valued at $17.5 Billion
2021-05-12
1 2 3 4 5 6 … 9
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top